IL33 and pulmonary fibrosis: However, the detailed molecular mechanism of IL-33 mediating weight loss and skeletal muscle atrophy through regulating whole-body metabolism during lung injury, including VILI, chronic COPD, and lung fibrosis, remains unknown.